Abstract: This invention discloses methods and apparatus for providing an ophthalmic lens with a stacked integrated component device for function. In some embodiments, the stacked integrated component device may contain an energy source capable of powering an electrical component incorporated into the lens.
Type:
Grant
Filed:
July 10, 2015
Date of Patent:
April 11, 2017
Assignee:
Johnson & Johnson Vision Care, Inc.
Inventors:
Frederick A. Flitsch, Daniel B. Otts, Randall B. Pugh
Abstract: Systems and methods are provided for detecting traffic signs. In one implementation, a traffic sign detection system for a vehicle include at least one image capture device configured to acquire at least one image of a scene including a traffic sign ahead of the vehicle. The traffic sign detection system also includes a data interface and at least one processing device programmed to receive the at least one image via the data interface, transform the at least one image, sample the transformed at least one image to generate a plurality of images having different sizes, convolve each of the plurality of images with a template image, compare each pixel value of each convolved image to a predetermined threshold, and select local maxima of pixel values within local regions of each convolved image as attention candidates, the local maxima being greater than the predetermined threshold.
Abstract: The present invention discloses methods and apparatus for forming a Viewing Set of Ophthalmic Lenses for Three-dimensional Perception of stereoscopic media and includes the resulting Viewing Set devices. The Viewing Sets include a left Ophthalmic Lens and a right Ophthalmic Lens, wherein each Ophthalmic Lens includes a translation filter that, when combined, allow for Three-dimensional Perception. The present invention also includes embodiments where the translation filters are included in an encapsulated Rigid Insert or Media Insert, wherein the Media Insert includes a variable optic zone.
Type:
Grant
Filed:
March 15, 2013
Date of Patent:
April 4, 2017
Assignee:
Johnson & Johnson Vision Care, Inc.
Inventors:
Randall B. Pugh, Karson S. Putt, Edward R. Kernick, Daniel Preza, Frederick A. Flitsch, Camille Higham, Sharika Snook
Abstract: An ophthalmic lens having an electronic system as described herein for providing an alarm to the wearer of the ophthalmic lens. In at least one embodiment, the system includes a lens, a timing circuit, a communications system, an alert mechanism and a system controller. In at least one embodiment, the lens provides an escalation of alarms to the wearer and/or responds to the wearer's input regarding the alarm.
Abstract: Disclosed in this specification is a method for forming a silicone hydrogel material that is useful for forming contact lens materials. The method includes using an effective amount of a borate additive to reduce the gel time of the silicone hydrogel reactive mixture and/or enhance the optical properties of the resulting cured material.
Abstract: The present invention relates to a process comprising the steps of reacting a reactive mixture comprising at least one silicone-containing component, at least one hydrophilic component, and at least one diluent to form an ophthalmic device having an advancing contact angle of less than about 80°; and contacting the ophthalmic device with an aqueous extraction solution at an elevated extraction temperature, wherein said at least one diluent has a boiling point at least about 10° higher than said extraction temperature.
Type:
Grant
Filed:
December 15, 2015
Date of Patent:
April 4, 2017
Assignee:
Johnson & Johnson Vision Care, Inc.
Inventors:
Azaam Alli, James D. Ford, Scott L. Joslin
Abstract: This invention discloses apparatus for generating an ophthalmic lens with at least a portion of one surface free-formed from a Reactive Mixture. In some embodiments, an ophthalmic lens is formed on a substrate with an arcuate optical quality surface via a source of actinic radiation controllable to cure a definable portion of a volume of Reactive Mixture.
Type:
Grant
Filed:
October 24, 2013
Date of Patent:
April 4, 2017
Assignee:
Johnson & Johnson Vision Care, Inc.
Inventors:
Michael F Widman, John B Enns, I, P Mark Powell, Peter W Sites
Abstract: The present invention relates to ionic silicone hydrogel polymers comprising at least one pharmaceutical or nutriceutical component and displaying improved lysozyme uptake, low contact angle and reduced water soluble polymeric ammonium salt uptake.
Type:
Grant
Filed:
March 13, 2015
Date of Patent:
April 4, 2017
Assignee:
Johnson & Johnson Vision Care, Inc.
Inventors:
Shivkumar Mahadevan, Zohra Fadli, Charles Scales, Thomas Maggio, Kunisi Venkatasubban, Eric R. George, James D. Ford, Carrie L. Davis, Leah Hansen, Scott L. Joslin, Douglas G. Vanderlaan, Ranganath Raja, Sharmila Muthukrishnan, C. Surendran, R. Sridharan
Abstract: An image sensor and a pre-processing circuit adapted to associate weights respectively with cells of a grid. The cells respectively may include multiple contiguous picture elements of the image sensor. The pre-processing circuit may be configured to adaptively change the weights responsive to changes in the scene being imaged by the image sensor. The number of the cells per distance on the surface of the image sensor may be substantially less than the resolution of the image sensor. The cells which share the same weights may specify a region of interest on the image sensor.
Abstract: An ophthalmic lens operable to protect the eye from harmful ultraviolet and high energy visible wavelengths of light and methods for producing the same.
Type:
Application
Filed:
September 29, 2016
Publication date:
March 30, 2017
Applicant:
Vision Ease, LP
Inventors:
Steven Harold Nahm, Richard Blacker, David Kissel, David Olund
Abstract: This invention discloses methods and apparatus for providing a variable optic insert into an ophthalmic lens. The variable optic insert may have surfaces within that have differing radii of curvature. A liquid crystal layer may be used to provide a variable optic function and in some embodiments, an alignment layer for the liquid crystal layer may be patterned in a radially dependent manner. The patterning may allow for the index of refraction of the optic device to vary in a gradient-indexed or GRIN manner. An energy source is capable of powering the variable optic insert included within the ophthalmic lens. In some embodiments, an ophthalmic lens is cast-molded from a silicone hydrogel. The various ophthalmic lens entities may include electroactive liquid crystal layers to electrically control optical characteristics.
Type:
Application
Filed:
August 27, 2014
Publication date:
March 30, 2017
Applicant:
Johnson & Johnson Vision Care, Inc.
Inventors:
Luciano De Sio, Frederick A. Flitsch, Praveen Pandojirao-S, Randall Braxton Pugh, James Daniel Riall, Svetlana Serak, Nelson V. Tabirian, Adam Toner, Olena Uskova
Abstract: A timing device comprises a sensing material and/or a component which is sensitive to the presence of an environmental attribute. The environmental attribute drives and speeds up or slows the timing device as the concentration of the attribute increases or decreases, respectively. Alternatively, the timing device is activated upon sensing the presence of the environmental attribute and indicates a total passage of time from exposure/activation of the timing device. Particularly, sensing materials of varying types are able to be used to indicate exposure to a variety of substances. For example, in some embodiments, the timing device comprises a sensing material which is sensitive to the presence of ultraviolet radiation. Alternatively, the sensing material is sensitive to other variables such as x-ray radiation and nuclear radiation. In further embodiments, the sensing material is sensitive to biological or physical contamination.
Abstract: Systems and methods are described for stabilizing an eye for an ocular laser procedure while minimizing corneal distortions which can adversely affect a surgical laser beam. For the systems, a patient interface includes a contact element for stabilizing the eye and establishing a conformal interface with the anterior surface of the cornea. More specifically, devices are disclosed which overlay both a central corneal region and a peripheral corneal region. In some embodiments, a first material is used in the contact element to overlay the central corneal region and a second material is used in the contact element to overlay the peripheral corneal region. Typically, the first and second materials differ in terms of hardness and deformability. In another embodiment disclosed herein, a contact element having a viscoelastic material for stabilizing an eye for a laser procedure is described.
Type:
Grant
Filed:
March 12, 2013
Date of Patent:
March 28, 2017
Assignee:
Technolas Perfect Vision GmbH
Inventors:
Markus Hailmann, Florian Dambacher, Frieder Loesel, Gwillem Mosedale
Abstract: A system and method for determining an objective quality metric for image data collected by a wavefront aberrometer. The method may include quantifying a plurality of characteristics of the image data and calculating the objective quality metric based on the quantified characteristics of the image data. The objective quality metric can be a weighted sum of the quantified characteristics of the image data. The weightings for the weighted sum can be determined based on subjective quality metrics assigned to a set of training image data by a human expert.
Type:
Grant
Filed:
November 3, 2014
Date of Patent:
March 28, 2017
Assignee:
WaveTec Vision Systems, Inc.
Inventors:
Edwin Jay Sarver, Thomas D. Padrick, Max Hall
Abstract: An apparatus, system, and method are provided for energy conversion. For example, the apparatus can include a trans-impedance node, a reactive element, and a trans-impedance circuit. The reactive element can be configured to transfer energy to the trans-impedance node. The trans-impedance circuit can be configured to receive one or more control signals and to dynamically adjust an impedance of the trans-impedance node. The trans-impedance node, as a result, can operate as an RF power switching supply based on the one or more control signals.
Abstract: The present invention relates to ophthalmic solutions and devices comprising at least one water soluble polymer having a molecular weight of at least about 500,000 Daltons and comprising linear or branched polyether pendant groups having a molecular weight of at least about 300.
Type:
Grant
Filed:
October 27, 2016
Date of Patent:
March 28, 2017
Assignee:
Johnson & Johnson Vision Care, Inc.
Inventors:
Frank Molock, Kathrine Osborn Lorenz, Shivkumar Mahadevan
Abstract: The disclosure describes prodrugs and derivatives of prostaglandins, carbonic anhydrase inhibitors, kinase inhibitors, beta-adrenergic receptor antagonists and other drugs, as well as controlled delivery formulations containing such prodrugs and derivatives, for the treatment of ocular disorders.
Type:
Application
Filed:
September 22, 2016
Publication date:
March 23, 2017
Applicant:
Graybug Vision, Inc.
Inventors:
Jeffrey L. Cleland, Ming Yang, John G. Bauman, Nu Hoang
Abstract: The present invention relates to ionic silicone hydrogel polymers displaying improved lysozyme uptake, low contact angle and reduced water soluble polymeric ammonium salt uptake.
Type:
Grant
Filed:
September 2, 2015
Date of Patent:
March 21, 2017
Assignee:
Johnson & Johnson Vision Care, Inc.
Inventors:
Shivkumar Mahadevan, Zohra Fadli, Charles Scales, Thomas Maggio, Kunisi Venkatasubban, Eric R. George, James D. Ford, Carrie L. Davis, Leah Hansen, Scott L. Joslin
Abstract: A method for the treatment of amblyopia comprising the steps of diagnosis and approval of a patient by a medical practitioner, providing access to an eye-training platform for the approved patient and instructions to the approved patient on using the eye-training platform, preparation of a therapy protocol by the medical practitioner, use of the eye-training platform according to the therapy protocol, recordal of patient results, intermediate examination of the patient and review of patient results, further use of the eye-training platform according to a modified therapy protocol, recordal of further user results, and examination of visual acuity and review of user results by the medical practitioner.